SI9011006B - Novi 8-substituirani-2-aminotetralini - Google Patents

Novi 8-substituirani-2-aminotetralini Download PDF

Info

Publication number
SI9011006B
SI9011006B SI9011006A SI9011006A SI9011006B SI 9011006 B SI9011006 B SI 9011006B SI 9011006 A SI9011006 A SI 9011006A SI 9011006 A SI9011006 A SI 9011006A SI 9011006 B SI9011006 B SI 9011006B
Authority
SI
Slovenia
Prior art keywords
formula
alkyl
compound
aryl
hydrogen
Prior art date
Application number
SI9011006A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9011006A (en
Inventor
Nils-Erik Anden
Hoeoek Berit Christina Elisabet Backlund
Anna Lena Maria Bjoerk
Uli Alf Hacksell
Sven-Erik Hillver
Ye Liu
Eva Charlotta Mellin
Eva Marie Persson
Karl Jerk Vallgarda
Hong Yu
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of SI9011006A publication Critical patent/SI9011006A/sl
Publication of SI9011006B publication Critical patent/SI9011006B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
SI9011006A 1989-05-26 1990-05-23 Novi 8-substituirani-2-aminotetralini SI9011006B (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8901889A SE8901889D0 (sv) 1989-05-26 1989-05-26 Novel 8-substituted-2-aminotetralines
YU100690A YU48830B (sh) 1989-05-26 1990-05-23 Novi 8-supstituisani-2-aminotetralini

Publications (2)

Publication Number Publication Date
SI9011006A SI9011006A (en) 1997-12-31
SI9011006B true SI9011006B (sl) 1998-12-31

Family

ID=20376074

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9011006A SI9011006B (sl) 1989-05-26 1990-05-23 Novi 8-substituirani-2-aminotetralini

Country Status (41)

Country Link
US (1) US5635537A (de)
EP (1) EP0399982B1 (de)
JP (1) JP2818692B2 (de)
KR (1) KR100193981B1 (de)
CN (1) CN1023399C (de)
AT (1) ATE129696T1 (de)
AU (1) AU644081B2 (de)
CA (1) CA2032498C (de)
CY (1) CY1989A (de)
CZ (1) CZ286038B6 (de)
DD (1) DD298909A5 (de)
DE (1) DE69023274T2 (de)
DK (1) DK0399982T3 (de)
DZ (1) DZ1417A1 (de)
ES (1) ES2078962T3 (de)
FI (1) FI114151B (de)
GR (1) GR3018566T3 (de)
HK (1) HK55697A (de)
HR (1) HRP920622B1 (de)
HU (2) HUT58685A (de)
IE (1) IE75057B1 (de)
IL (1) IL94428A (de)
IS (1) IS1663B (de)
JO (1) JO1617B1 (de)
LT (1) LT3966B (de)
LV (2) LV10243B (de)
MX (1) MX20842A (de)
NO (1) NO176603C (de)
NZ (1) NZ233724A (de)
PH (1) PH31110A (de)
PL (2) PL164245B1 (de)
PT (1) PT94163B (de)
RU (1) RU2093507C1 (de)
SA (1) SA90100274B1 (de)
SE (1) SE8901889D0 (de)
SI (1) SI9011006B (de)
SK (1) SK256090A3 (de)
UA (1) UA40562C2 (de)
WO (1) WO1990014330A1 (de)
YU (1) YU48830B (de)
ZA (1) ZA903801B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2086535C1 (ru) 1989-05-31 1997-08-10 Дзе Апджон Компани Производные 1,2,3,4-тетрагидро-2-нафтиламина
DK0471515T3 (da) * 1990-08-15 1997-07-21 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronphtalener, 3-aminochromaner og 3-aminothiochromaner
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ241495A (en) * 1991-02-08 1994-10-26 Lilly Co Eli 2-amino-1,2,3,4-tetrahydronaphthalene and 3-aminochromane derivative, preparation and pharmaceutical compositions thereof
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
US5641794A (en) * 1991-03-28 1997-06-24 Eli Lilly Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
WO1996015099A1 (en) * 1994-11-09 1996-05-23 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
GB9509156D0 (en) 1995-05-05 1995-06-28 Sandoz Ltd Organic compounds
ES2566479T3 (es) 2006-01-06 2016-04-13 Sunovion Pharmaceuticals Inc. Inhibidores de reabsorción de monoamina con base en tetralona
AU2022238849A1 (en) 2021-03-17 2023-08-31 Receptos Llc Methods of treating atopic dermatitis with anti il-13 antibodies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4247907A (en) * 1978-11-27 1981-01-27 International Business Machines Corporation Method and apparatus for typing characters and optically readable binary representations thereof on same page
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
DE3479314D1 (en) * 1984-05-22 1989-09-14 Nelson Res & Dev Substituted 2-aminotetralins and processes for synthesis
DE3660959D1 (de) * 1985-06-26 1988-11-24 Smithkline Beckman Corp Benz-trisubstituted 2-aminotetralins
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
AU4844290A (en) * 1989-01-09 1990-08-01 Upjohn Company, The Halo substituted aminotetralins
RU2086535C1 (ru) * 1989-05-31 1997-08-10 Дзе Апджон Компани Производные 1,2,3,4-тетрагидро-2-нафтиламина

Also Published As

Publication number Publication date
DE69023274T2 (de) 1996-04-11
LT3966B (en) 1996-05-27
AU5818590A (en) 1990-12-18
LV10243B (en) 1995-04-20
PH31110A (en) 1998-02-23
NO910310D0 (no) 1991-01-25
DD298909A5 (de) 1992-03-19
MX20842A (es) 1993-11-01
ATE129696T1 (de) 1995-11-15
AU644081B2 (en) 1993-12-02
HK55697A (en) 1997-05-09
YU100690A (en) 1992-05-28
CN1047494A (zh) 1990-12-05
KR100193981B1 (ko) 1999-06-15
PT94163B (pt) 1996-12-31
JPH04500362A (ja) 1992-01-23
IS1663B (is) 1997-07-04
NZ233724A (en) 1993-01-27
SE8901889D0 (sv) 1989-05-26
CN1023399C (zh) 1994-01-05
EP0399982B1 (de) 1995-11-02
GR3018566T3 (en) 1996-03-31
CY1989A (en) 1997-09-05
LV11736B (en) 1997-10-20
IS3580A7 (is) 1990-11-27
IE901833L (en) 1990-11-26
CA2032498A1 (en) 1990-11-27
RU2093507C1 (ru) 1997-10-20
US5635537A (en) 1997-06-03
HU904810D0 (en) 1991-06-28
YU48830B (sh) 2002-03-18
LTIP1723A (en) 1995-08-25
HRP920622A2 (en) 1998-06-30
SA90100274B1 (ar) 2005-06-01
ES2078962T3 (es) 1996-01-01
PT94163A (pt) 1991-01-08
LV11736A (lv) 1997-04-20
FI910381A0 (fi) 1991-01-25
IE75057B1 (en) 1997-08-27
DZ1417A1 (fr) 2004-09-13
JP2818692B2 (ja) 1998-10-30
IL94428A (en) 1995-12-31
HRP920622B1 (en) 2000-04-30
SI9011006A (en) 1997-12-31
DK0399982T3 (da) 1996-03-04
KR920701121A (ko) 1992-08-11
IL94428A0 (en) 1991-03-10
LV10243A (lv) 1994-10-20
ZA903801B (en) 1991-01-30
NO176603B (no) 1995-01-23
HU211880A9 (en) 1995-12-28
UA40562C2 (uk) 2001-08-15
CA2032498C (en) 2002-03-26
PL164245B1 (pl) 1994-07-29
WO1990014330A1 (en) 1990-11-29
PL165166B1 (pl) 1994-11-30
SK280731B6 (sk) 2000-07-11
NO176603C (no) 1995-05-03
EP0399982A1 (de) 1990-11-28
SK256090A3 (en) 2000-07-11
DE69023274D1 (de) 1995-12-07
CZ256090A3 (cs) 1999-10-13
PL285330A1 (en) 1991-11-04
FI114151B (fi) 2004-08-31
JO1617B1 (en) 1991-11-27
CZ286038B6 (cs) 1999-12-15
NO910310L (no) 1991-01-25
HUT58685A (en) 1992-03-30

Similar Documents

Publication Publication Date Title
SI9011006B (sl) Novi 8-substituirani-2-aminotetralini
RU2220967C2 (ru) Арилпиперазины, способы их получения, фармацевтическая композиция
RU2005109913A (ru) Азабициклоалкильные эфиры и их применение в качестве агонистов альфа7-nachr
CH616674A5 (de)
KR920701193A (ko) 신규 크로만 및 티오크로만 유도체
JPS6110583A (ja) ピラゾ−ル環がアルキル化されたピラゾロキノリン類およびその製造中間体
RU94046047A (ru) Производные аминоуксусной кислоты в виде рацемата или d- и l-энантиомеров и их фармацевтически приемлемые соли, способ получения d- и l-энантиомеров производных аминоуксусной кислоты или их фармацевтически приемлемых солей и промежуточные d- и l-энантиомеры аминоуксусной кислоты в виде цинхонидиновой соли
Campaigne et al. Synthesis of β-Dimethylaminoethyl and α-Hydroxy-β-Dimethylaminoethyl Derivatives from Organolithium Compounds and Tetramethyoxamide
Zheng et al. Access to thiazoline and spiro [indoline-3, 3′-thiophene] scaffolds via a formal [3+ 2] annulation reaction of crotonate-derived sulfur ylides and β-ketothioamides
NZ511157A (en) Derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol
Kriis et al. Asymmetric synthesis of 2, 3, 4-trisubstituted piperidines
EP0009465A1 (de) N-(1-(4-Amino-2-chinazolinyl)-3- oder -4-piperidyl-lactame, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen
EP0409163B1 (de) Cyclische vinyloge N-hydroxy-N-methylharnstoffe verwendbar als 5-Lipoygenase-Inhibitoren
SU569280A3 (ru) Способ получени аралкиловых эфиров аминокислот или их солей
KR900006289A (ko) 염기성 4-아릴-dhp 아미드, 그의 제조 방법 및 의약품으로서 그의 용도
KR101057304B1 (ko) 키랄 촉매를 이용한 아스파르트산 유도체의 제조방법
WO2023054626A1 (ja) シクロプロパンアミド誘導体
SK67295A3 (en) Phenylethylamine and phenylpropylamine, manufacturing process thereof and pharmaceutical composition containing them
HU176277B (en) Process for producing cycloalkyl-amine derivatives
EA200000527A3 (ru) Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их
TH8849A (th) 8-ซับสทิทิวเทด-2-อะมิโนเททระลีนชนิดใหม่
OTOMASU et al. Synthesis of Condensed Quinoxalines. II. A New Synthesis of Pyrrolo-[2, 3-b] quinoxalines
EP1204636A1 (de) 3-oxo-1-propansulfonsäure und -sulfonate
TH21386B (th) 8-ซับสทิทิวเทด-2-อะมิโนเททระลีนชนิดใหม่
US3437689A (en) Aromatic amino acid

Legal Events

Date Code Title Description
IF Valid on the event date